Among those LAML tumors that have fusions and no driver gene mutations, we identified several well-recognized fusions relevant to leukemia, such as CBFB–MYH11 (number of samples = 3), BCR–ABL1 (n = 2), and PML–RAR (n = 2). This evidence concerns the gene BCR and leukemia.